Aurinia Pharmaceuticals Inc (AUPH)
7.225
-0.06
(-0.89%)
USD |
NASDAQ |
Oct 04, 15:37
Aurinia Pharmaceuticals Shareholders Equity (Quarterly): 392.29M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 392.29M |
March 31, 2023 | 390.41M |
December 31, 2022 | 405.44M |
September 30, 2022 | 423.42M |
June 30, 2022 | 423.77M |
March 31, 2022 | 448.12M |
December 31, 2021 | 479.09M |
September 30, 2021 | 298.17M |
June 30, 2021 | 332.26M |
March 31, 2021 | 370.23M |
December 31, 2020 | 407.75M |
June 30, 2020 | 239.04M |
March 31, 2020 | 263.41M |
December 31, 2019 | 298.60M |
September 30, 2019 | 123.74M |
June 30, 2019 | 125.87M |
March 31, 2019 | 139.34M |
December 31, 2018 | 112.58M |
September 30, 2018 | 125.34M |
June 30, 2018 | 142.17M |
March 31, 2018 | 152.45M |
December 31, 2017 | 165.74M |
September 30, 2017 | 167.64M |
June 30, 2017 | 178.46M |
March 31, 2017 | 172.66M |
Date | Value |
---|---|
December 31, 2016 | 35.95M |
September 30, 2016 | 20.10M |
June 30, 2016 | 19.54M |
March 31, 2016 | 16.02M |
December 31, 2015 | 19.96M |
September 30, 2015 | 23.54M |
June 30, 2015 | 28.01M |
March 31, 2015 | 27.56M |
December 31, 2014 | 33.87M |
September 30, 2014 | 49.32M |
June 30, 2014 | 51.07M |
March 31, 2014 | 54.62M |
December 31, 2013 | 13.31M |
September 30, 2013 | 12.23M |
June 30, 2013 | -2.894M |
March 31, 2013 | -2.921M |
December 31, 2012 | -2.118M |
September 30, 2012 | 2.208M |
June 30, 2012 | 3.772M |
March 31, 2012 | 6.157M |
December 31, 2011 | 6.411M |
September 30, 2011 | 12.47M |
June 30, 2011 | 10.82M |
March 31, 2011 | 5.908M |
December 31, 2010 | 6.348M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
112.58M
Minimum
Dec 2018
479.09M
Maximum
Dec 2021
315.20M
Average
351.24M
Median
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 64.01M |
Edesa Biotech Inc | 7.850M |
Lexaria Bioscience Corp | 4.396M |
Liminal Biosciences Inc | 16.20M |
Xenon Pharmaceuticals Inc | 646.46M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 548.90M |
Total Liabilities (Quarterly) | 156.61M |
Current Ratio | 6.745 |